Publications from completed UCARE scientific projects can be found here.

PREG-CU

Kocatürk E, Al-Ahmad M, Krause K, Gimenez-Arnau AM, Thomsen SF, Conlon N, Marsland A, Savk E, Criado RF, Danilycheva I, Fomina D, Godse K, Khoshkhui M, Gelincik A, Degirmentepe EN, Demir S, Ensina LF, Kasperska-Zajac A, Rudenko M, Valle S, Medina I, Bauer A, Zhao Z, Staubach P, Bouillet L, Küçük ÖS, Ateş C, Maurer M. Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study. Allergy. 2021 Oct;76(10):3133-3144. doi: 10.1111/all.14950. Epub 2021 Jun 12. PMID: 34022061.

 

Kocatürk E, Al-Ahmad M, Krause K, Gimenez-Arnau AM, Thomsen SF, Conlon N, Marsland A, Savk E, Criado RF, Danilycheva I, Fomina D, Godse K, Khoshkhui M, Gelincik A, Degirmentepe EN, Demir S, Ensina LF, Kasperska-Zajac A, Rudenko M, Valle S, Medina I, Bauer A, Zhao Z, Staubach P, Bouillet L, Küçük ÖS, Baygül A, Maurer M. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study. J Eur Acad Dermatol Venereol. 2022 Sep 6. doi: 10.1111/jdv.18574. Online ahead of print.

Kocatürk E, Thomsen SF, Al-Ahmad M, Gimenez Arnau AM, Conlon N, Şavk E, Criado RFJ, Danilycheva I, Fomina D, Khoshkhui M, Gelincik A, Yüksel EN, Ertan S, Ensina LF, Kasperska-Zajac A, Rudenko M, Bauer A, Medina IV, Maurer M. Total IgE levels are linked to the course of chronic spontaneous urticaria during pregnancy. J Allergy Clin Immunol Pract. 2022 Oct 26:S2213-2198(22)01061-3. doi: 10.1016/j.jaip.2022.10.018. Online ahead of print.

COLD-CE

Publication 1:

Bizjak M, Košnik M, Dinevski D, Thomsen SF, et. al. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study. Allergy. 2021 Dec 4. doi: 10.1111/all.15194. Epub ahead of print.


Publication 2:

Bizjak M, Košnik M, Dinevski D, Thomsen SF, et al. Adrenaline autoinjector is underprescribed in typical cold urticaria patients. Allergy. 2022 Jul;77(7):2224-2229. doi: 10.1111/all.15274. Epub 2022 Mar 14. PMID: 35258111.

CURICT

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clin Transl Allergy. 2021 Dec;11(10):e12089. doi: 10.1002/clt2.12089. PMID: 34962721; PMCID: PMC8684305.

Maurer M, Weller K, Magerl M, et. al. The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study. World Allergy Organ J. 2020 Oct 30;13(11):100475. doi: 10.1016/j.waojou.2020.100475. PMID: 33204387; PMCID: PMC7606865.

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RF, Abuzakouk M, Grandon D, Van Doorn MBA, Oliveira Rodrigues Valle S, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ J. 2021 Jun 4;14(6):100542. doi: 10.1016/j.waojou.2021.100542. PMID: 34141048; PMCID: PMC8190491.

Synopsis CURICT

COVAC-CU

Purayil S, Thalappil S, Al-Nesf M, Kocaturk E. Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international). Qatar Med J. 2022 Apr 4;2022(2):2. doi: 10.5339/qmj.2022.fqac.2. PMID: 35968517; PMCID: PMC9340567.

Other Publications

Management of urticarial vasculitis: A worldwide physician perspective.

Kolkhir P, Bonnekoh H, Kocatürk E, Hide M, Metz M, Sánchez-Borges M, Krause K, Maurer M.

World Allergy Organ J. 2020 Mar 5;13(3):100107. doi: 10.1016/j.waojou.2020.100107. eCollection 2020 Mar.PMID: 32180892

Clinical experience of a specialized urticaria outpatient clinic from a Portuguese UCARE.

Esteves Caldeira L, Paulino M, Coutinho C, Neto M, Pereira Barbosa M, Costa C.

Eur Ann Allergy Clin Immunol. 2021 May 5. doi: 10.23822/EurAnnACI.1764-1489.209. Online ahead of print. PMID: 33949172

TempTest®: un instrumento de precisión en las urticarias físicas.

Rodrigues-Valle S, Azizi G, Duarte-Dortas S Jr.

Rev Alerg Mex. 2021 Jan-Mar;68(1):2-6. doi: 10.29262/ram.v68i1.827. PMID: 34148323 Spanish.

Expert consensus on practical aspects in the treatment of chronic urticaria.

Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M, Schliemann S, Schwichtenberg U, Staubach P, Valesky E, Wagner N, Wedi B, Maurer M.

Allergo J Int. 2021;30(2):64-75. doi: 10.1007/s40629-021-00162-w. Epub 2021 Feb 24.

PMID: 33643777 Free PMC article. Review.

Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres.

Can PK, Salman A, Hoşgören-Tekin S, Kocatürk E.

J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e679-e682. doi: 10.1111/jdv.17385. Epub 2021 Jun 12.

PMID: 34013560 No abstract available.